Congratulations to Dr. Mark Greenwald, who recently signed a contract for a new medical device FDA-qualifying clinical trial, NET Device as a Non-Pharmacological Alternative to Medication for Promoting Opioid Abstinence. As PI, Dr. Greenwald will be working with biostatistician Samiran Ghosh to evaluate the effectiveness of NET (NeuroElectric Therapy) in treating patients with opioid use disorder The study will be conducted at a single, high-throughput clinical treatment facility in rural Kentucky.